Diptoindonesin G antagonizes AR signaling and enhances the efficacy of antiandrogen therapy in prostate cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diptoindonesin G antagonizes AR signaling and enhances the efficacy of antiandrogen therapy in prostate cancer
Authors
Keywords
-
Journal
PROSTATE
Volume 82, Issue 8, Pages 917-932
Publisher
Wiley
Online
2022-03-25
DOI
10.1002/pros.24336
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance
- (2020) Chaohao Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cellular rewiring in lethal prostate cancer: the architect of drug resistance
- (2020) Marc Carceles-Cordon et al. Nature Reviews Urology
- p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate Cancer
- (2020) Songhui Xu et al. CANCER RESEARCH
- Triggering a switch from basal- to luminal-like breast cancer subtype by the small-molecule diptoindonesin G via induction of GABARAPL1
- (2020) Minmin Fan et al. Cell Death & Disease
- Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
- (2019) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide-resistance in castration-resistance prostate cancer
- (2019) Yunfeng Bai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells
- (2019) Elia Farah et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
- (2019) Qin Feng et al. Frontiers in Oncology
- Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration‐resistant prostate cancer
- (2019) Xiaoliang Chen et al. PROSTATE
- Plk1-Mediated Phosphorylation of TSC1 Enhances the Efficacy of Rapamycin
- (2018) Zhiguo Li et al. CANCER RESEARCH
- Inhibition of the Wnt/β-catenin pathway overcomes resistance to enzalutamide in castration-resistant prostate cancer
- (2018) Zhuangzhuang Zhang et al. CANCER RESEARCH
- Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer
- (2018) Fengyi Mao et al. MOLECULAR CANCER THERAPEUTICS
- Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
- (2018) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC)
- (2018) Yifan Kong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of Androgen Receptor in Prostate Cancer: A Review
- (2018) Kazutoshi Fujita et al. World Journal of Mens Health
- Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer
- (2018) Chengfei Liu et al. Nature Communications
- Aurora Kinase A Promotes AR Degradation via the E3 Ligase CHIP
- (2017) Sukumar Sarkar et al. MOLECULAR CANCER RESEARCH
- Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer
- (2017) Jie Li et al. MOLECULAR CANCER THERAPEUTICS
- Diptoindonesin G promotes ERK-mediated nuclear translocation of p-STAT1 (Ser727) and cell differentiation in AML cells
- (2017) Jian Gao et al. Cell Death & Disease
- Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells
- (2016) R. Ferraldeschi et al. CANCER RESEARCH
- Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer
- (2016) L. Chen et al. MOLECULAR CANCER THERAPEUTICS
- A Decade of Boon or Burden: What Has the CHIP Ever Done for Cellular Protein Quality Control Mechanism Implicated in Neurodegeneration and Aging?
- (2016) Vibhuti Joshi et al. Frontiers in Molecular Neuroscience
- Inhibition of Plk1 represses androgen signaling pathway in castration-resistant prostate cancer
- (2015) Zhe Zhang et al. CELL CYCLE
- Reciprocal Regulation of ERα and ERβ Stability and Activity by Diptoindonesin G
- (2015) Zibo Zhao et al. CHEMISTRY & BIOLOGY
- Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
- (2015) A. A. Azad et al. CLINICAL CANCER RESEARCH
- 17-ABAG, a novel geldanamycin derivative, inhibits LNCaP-cell proliferation through heat shock protein 90 inhibition
- (2015) ZHIYUAN LIN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer
- (2015) Jie Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment
- (2015) Xiaoqi Liu Translational Oncology
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- Plk1 Inhibition Enhances the Efficacy of Androgen Signaling Blockade in Castration-Resistant Prostate Cancer
- (2014) Z. Zhang et al. CANCER RESEARCH
- Inhibition of Polo-like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer
- (2014) Chen Shao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Plk1 Phosphorylation of PTEN Causes a Tumor-Promoting Metabolic State
- (2014) Z. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Posttranslational Modification of the Androgen Receptor in Prostate Cancer
- (2013) Travis Van der Steen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanisms of the androgen receptor splicing in prostate cancer cells
- (2013) L L Liu et al. ONCOGENE
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
- (2012) Karim Fizazi et al. LANCET ONCOLOGY
- Androgen receptor (AR) aberrations in castration-resistant prostate cancer
- (2012) Kati K. Waltering et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells
- (2012) S Sarkar et al. ONCOGENE
- The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity
- (2012) I Paul et al. ONCOGENE
- Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy
- (2012) David R. Yates et al. PROSTATE
- The Hsp90 chaperone machinery: Conformational dynamics and regulation by co-chaperones
- (2011) Jing Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Phosphorylation of CLIP-170 by Plk1 and CK2 promotes timely formation of kinetochore–microtubule attachments
- (2010) Hongchang Li et al. EMBO JOURNAL
- Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear envelope breakdown during prophase
- (2010) H. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer
- (2008) J. A. Locke et al. CANCER RESEARCH
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
- From hatching to dispatching: the multiple cellular roles of the Hsp70 molecular chaperone machinery
- (2008) Eirini Meimaridou et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Chaperone-dependent stabilization and degradation of p53 mutants
- (2008) P Muller et al. ONCOGENE
- Adapting Proteostasis for Disease Intervention
- (2008) William E. Balch et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started